Edwards Lifesciences (NYSE: EW)
Edwards Lifesciences Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Edwards Lifesciences Company Info
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
News & Analysis
Why Edwards Lifesciences Stock Plummeted Today
Investors trade on future potential rather than trailing results, and they found the company's top-line guidance wanting.
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains.
Why Edwards Lifesciences Stock Crashed 16% Today
Did investors overreact to the company's miss?
3 Unstoppable Investments Everyone Needs in Their Portfolio
There are still some names out there that can thrive in any environment.
Edwards Lifesciences Blows Past Q2 Earnings Estimates
But the coronavirus pandemic continues to create uncertainty for the medical device maker.
Abbott Laboratories and Edwards Lifesciences Settle Patent Fight
The two companies' agreement puts to rest an escalating dispute over heart valve repair products.
Could Edwards Lifesciences Be a Millionaire-Maker Stock?
Strong revenue growth and low debt make this stock a winner.
Why Edwards Lifesciences Shares Rose 15.3% in April
Positive trial results, sales growth, and general market gains led the shares higher.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.